Peterborough City Hospital
Peterborough, United Kingdom
Teaching hospital in Peterborough, England
Edith Cavell Campus, Bretton Gate, Peterborough PE3 9GZ
612 Beds
About Peterborough City Hospital
Peterborough City Hospital is an acute teaching hospital on the Edith Cavell Healthcare Campus serving the city of Peterborough, north Cambridgeshire, areas of east Northamptonshire and Rutland. It is managed by North West Anglia NHS Foundation Trust.
There are 612 beds in Peterborough City Hospital.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
5
Peterborough and Stamford Hospitals NHS Foundation Trust
2
University of Oxford
2
Australian and New Zealand Intensive Care Research Centre
1
Boehringer Ingelheim
1
Brynn Chappell
1
CCTU- Cancer Theme
1
Cambridge University Hospitals NHS Foundation Trust
1
Daiichi Sankyo, Inc.
1
ImmunoGen, Inc.
1
Imperial College London
1
Clinical Trials at Peterborough City Hospital
During the past decade, Peterborough City Hospital conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 8 clinical trials were completed, i.e. on
average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 6 clinical trials were completed. i.e. 150%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Evaluation of Topical 10% Metronidazole Ointment for the Treatment of Active Perianal Crohn's Disease
2005-05-01
2008-02-01
Completed
74
BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
2008-04-01
2014-07-01
Terminated
3,509
Modafinil for the Treatment of Fatigue in Lung Cancer V9.0
2009-02-01
2012-05-01
Completed
208
Randomised Trial Comparing Iron Supplementation Versus Placebo in the Treatment of Anaemia After Hip Fracture
2004-07-01
2009-08-01
Completed
300
International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)
2012-07-01
2023-05-30
Active, not recruiting
5,179
A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer
2012-06-01
2019-09-20
Completed
1,436
PIT: Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma
2012-07-01
2017-04-05
Terminated
375
Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast Cancer
2012-08-27
2017-11-21
Completed
481
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Peterborough City Hospital" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Peterborough and Stamford Hospitals NHS Foundation Trust" with 2 trials
sponsored, "University of Oxford" with 2 trials sponsored, "Australian and New Zealand Intensive Care Research Centre" with 1 trials sponsored and "Boehringer Ingelheim"
with 1 trials sponsored. Other sponsors include 19 different institutions and
companies that sponsored additional 29 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Peterborough City Hospital"
#1 collaborator was "Cancer Research UK" with 3 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Celgene" with 2 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 2 trials as a collaborator and "Academy of Finland" with 1 trials as a collaborator. Other collaborators include 42 different institutions and companies that were
collaborators in the rest 52 trials.
Clinical Trials Conditions at Peterborough City Hospital
According to Clinical.Site data, the most researched conditions in "Peterborough City Hospital" are
"Breast Cancer" (5 trials), "Atrial Fibrillation" (2 trials), "Fallopian Tube Cancer" (2 trials), "Hip Fractures" (2 trials) and "Metastatic Breast Cancer" (2 trials). Many other conditions were trialed in "Peterborough City Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Peterborough City Hospital
Most popular intervention types in "Peterborough City Hospital" are "Drug" (21 trials), "Procedure" (5 trials), "Other" (4 trials), "Device" (3 trials) and "Radiation" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Docetaxel" (4 trials), "Paclitaxel" (4 trials), "Cyclophosphamide" (2 trials) and "Trastuzumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Peterborough City Hospital
The vast majority of trials in "Peterborough City Hospital" are
30 trials for "All" genders and 5 trials for "Female" genders.
Clinical Trials Status at Peterborough City Hospital
Currently, there are NaN active trials in "Peterborough City Hospital".
undefined are not yet recruiting,
6 are recruiting,
7 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 16 completed trials in Peterborough City Hospital,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Peterborough City Hospital, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 17 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 8 trials that are defined as “Not Applicable".